In our study, we demonstrated that several ISGs including IFITM1, STAT1 and PLSCR1 and their encoded proteins are constitutively overexpressed in AI-resistant breast cancer cells and AI-resistant tumors and that their overexpression provides a survival advantage in the resistant cells. This evidence concerns the gene IFITM1 and breast carcinoma.